Devonian Health Group Inc.
DVHGF
$7.00
-$3.65-34.27%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -90.65% | -67.30% | -25.85% | 18.62% | 207.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.65% | -67.30% | -25.85% | 18.62% | 207.93% |
| Cost of Revenue | -95.28% | -72.27% | -27.99% | 23.19% | 198.52% |
| Gross Profit | -82.49% | -57.98% | -22.17% | 11.38% | 225.99% |
| SG&A Expenses | 2.50% | 10.60% | -15.83% | 4.90% | 62.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 5.69% | 4.24% | 1.78% | 1.45% | 0.45% |
| Total Operating Expenses | -70.22% | -51.84% | -20.33% | 18.73% | 132.18% |
| Operating Income | -668.60% | -615.49% | -216.76% | -22.16% | 137.42% |
| Income Before Tax | -65.20% | -1,726.07% | -615.87% | -438.69% | -15.23% |
| Income Tax Expenses | -101.26% | -100.99% | -51.93% | -51.93% | 264.05% |
| Earnings from Continuing Operations | -29.93% | -1,107.35% | -289.18% | -214.08% | -34.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.93% | -1,107.35% | -289.18% | -214.08% | -34.74% |
| EBIT | -668.60% | -615.49% | -216.76% | -22.16% | 137.42% |
| EBITDA | -527.28% | -444.35% | -733.66% | -99.72% | 156.83% |
| EPS Basic | -59.82% | -1,322.22% | -275.65% | -209.06% | -33.41% |
| Normalized Basic EPS | -889.90% | -1,166.47% | -68.70% | 26.67% | 129.33% |
| EPS Diluted | -59.82% | -1,322.22% | -227.18% | -170.53% | -23.97% |
| Normalized Diluted EPS | -889.90% | -1,106.99% | -74.88% | 24.34% | 129.62% |
| Average Basic Shares Outstanding | 36.94% | 34.08% | 3.41% | 0.82% | 0.97% |
| Average Diluted Shares Outstanding | 36.94% | 31.04% | 1.06% | -1.49% | -1.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |